Drug intelligence / Profile preview

Pylospey

Development stage
Unknown
Lead developer
Spey Medical
Modality
Small Molecules
Administration
Oral
01

Overview

Pylospey is an oral gastroprotective combination product developed by SPEY, formulated as capsules containing zinc L-carnosine (polaprezinc) and inactivated cells of a patented strain of Lactobacillus reuteri (DSM 17648). It is indicated for gastrological use, specifically to reduce Helicobacter pylori levels in the gastrointestinal tract and promote the healing of the gastric mucosa. Lactobacillus reuteri DSM 17648 physically binds and co-aggregates with H. pylori, facilitating its excretion from the stomach. Polaprezinc, a chelate of zinc and L-carnosine, acts as a mucosal protective agent by stimulating the expression of heat shock protein 70 (HSP70), scavenging reactive oxygen species (ROS), and inhibiting pro-inflammatory cytokines, thereby accelerating tissue repair and protecting the gastric lining.

Brand names
Pylospey
Other names
Lactobacillus reuteri + polaprezincLactobacillus reuteri + zinc L-carnosinepolaprezinc + Lactobacillus reuterizinc L-carnosine + Lactobacillus reuteri
02

Targets

HSP70 (Heat shock protein 70)PRDX5 (Peroxiredoxin-5)

Beyond the preview

Go deeper on Pylospey.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pylospey.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call